Similar articles

• Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.

  Faglia G, Gattinoni L, Travaglini P, Neri V, Acerbi L, Ambrosi B. Faglia G, et al. Metabolism. 1971 Mar;20(3):266-72. doi: 10.1016/0026-0495(71)90109-0. Metabolism. 1971. PMID: 5546922 No abstract available.
• Effect of aminoglutethimide on extraglandular metabolism of exogenous testosterone.

  Horky K, Kuchel O, Stárka L, Gregorová I. Horky K, et al. Metabolism. 1971 Mar;20(3):331-6. doi: 10.1016/0026-0495(71)90118-1. Metabolism. 1971. PMID: 4251108 No abstract available.
• Congenital adrenal hyperplasia due to deficiency of 11 -hydroxylation of 17 -hydroxylated steroids.

  Zachmann M, Völlmin JA, New MI, Curtius HC, Prader A. Zachmann M, et al. J Clin Endocrinol Metab. 1971 Sep;33(3):501-8. doi: 10.1210/jcem-33-3-501. J Clin Endocrinol Metab. 1971. PMID: 4328339 No abstract available.
• Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion.

  Masi AT, Josipović DB, Jefferson WE. Masi AT, et al. Semin Arthritis Rheum. 1984 Aug;14(1):1-23. doi: 10.1016/0049-0172(84)90005-2. Semin Arthritis Rheum. 1984. PMID: 6091273 Review.
• [Inhibition of adrenocortical steroid production in therapy].

  Bricaire H, Philbert M, Luton JP. Bricaire H, et al. Rev Fr Etud Clin Biol. 1968 Jun-Jul;13(6):563-7. Rev Fr Etud Clin Biol. 1968. PMID: 4178146 Review. French. No abstract available.